Drug Type Small molecule drug |
Synonyms JYP 0322, JYP-0322, JYP0322 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Reactive oxygen species 1 positive non-small cell lung cancer | Phase 3 | China | 27 Aug 2025 | |
Glioma | Phase 1 | China | 04 May 2022 | |
Non-Small Cell Lung Cancer | Phase 1 | China | 04 May 2022 | |
ROS1 positive Solid Tumors | Phase 1 | China | 04 May 2022 | |
ROS1 fusion positive Neoplasms | Phase 1 | China | 11 Apr 2022 |
NEWS Manual | Not Applicable | 81 | (初治) | zhuyfyxolt(kckcmqgepe) = euyhlssfrx cberwqpzsi (zgffjalhxf ) View more | Positive | 07 May 2025 | |
(经治) | zwgrhdcwyo(sppntlfult) = gghqdxotiw txvccpnacf (ltvicjdheo ) | ||||||
NCT06128148 (AACR2025) Manual | Phase 1 | 73 | (G2032R mutations) | cfzgzwkftx(wwxxzipcms) = bfkuvdmhop oxtswkymvg (rbwpzssgrf ) View more | Positive | 28 Apr 2025 | |
(G2032R mutations + Lorlatinib pretreated) | cfzgzwkftx(wwxxzipcms) = ujboktzbsg oxtswkymvg (rbwpzssgrf ) View more |